Harlequins hold a slim edge in trader consensus at 44.5% implied probability for their Gallagher Premiership clash against Sale Sharks at Twickenham Stoop, driven by home advantage despite a crippling injury list exceeding 25 players, including recent losses of Jarrod Evans, Nick David, and Cadan Murley following a 48-15 thrashing by Bath. Sale Sharks, at 39%, lurk close after a 26-17 Champions Cup win over Quins three weeks ago and boast George Ford's fifth-ranked 88 points, though their 0-6 away Premiership record and 85-19 drubbing by Saracens last weekend temper expectations. Both sides' WLWLL/LLWLL form, standout lineout steals from Quins flanker Guido Petti, and Sale's Ben Bamber's league-leading tackles underscore the razor-thin margins in this evenly matched Round 14 encounter.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedAll Sports
MLB
UFC
All
MLS
Bolivian Primera División
Liga FPD
Liga MX
Eliteserien
Chinese Super League
ÖFB Cup
NWSL
Brasileirão Série B
Allsvenskan
UEL
Liga 1
SuperLiga
UCL
Brasileirão Série A
UEFA Conference League
Australia Cup
Uruguayan Primera División
K League 2
Liga de Primera
K League 1
Danish Superliga
USL League One
Veikkausliiga
Chance Liga
Categoría Primera A
Copa Sudamericana
NB I
Scotland League Cup
Niké liga
Ekstraklasa
Swiss Super League
Superettan
OBOS-ligaen
Primera Nacional
efbet Liga
Scottish Premiership
Kazakhstan Premier League
A Lyga
League of Ireland Premier Division
LigaPro Serie A
Liga Nacional de Guatemala
Serbian SuperLiga
TFF Süper Kupa
Slovenia PrvaLiga
Besta deild karla
USL Championship
Categoría Primera B
Copa do Brasil
J2 League
Ukrainian Premier League
Premier League
LaLiga
Bundesliga
Ligue 1
Serie A
Liga Profesional de Fútbol
Women's Champions League
EFL CUP
Leagues Cup
Prva Liga
Primeira Liga
Saudi Pro League
Hockey
Volleyball
Golf
Cycling
Poker
Chess
Pickleball
Lacrosse
Esports
Harlequins – Sale Sharks
Moneyline
$686 Vol.
If Sale Sharks wins, this market will resolve to "Yes".
Otherwise, this market will resolve to "No".
If the game is postponed, this market will remain open until the game has been completed.
If the game is canceled entirely, with no make-up game, this market will resolve to "No".
This market refers only to the outcome when the ball becomes dead after 80 minutes of regular play.
Market Opened: Mar 29, 2026, 2:46 AM ET
Resolution Source
https://www.premiershiprugby.com/Resolver
0x69c47De9D...Harlequins – Sale Sharks
Moneyline
$686 Vol.
If Sale Sharks wins, this market will resolve to "Yes".
Otherwise, this market will resolve to "No".
If the game is postponed, this market will remain open until the game has been completed.
If the game is canceled entirely, with no make-up game, this market will resolve to "No".
This market refers only to the outcome when the ball becomes dead after 80 minutes of regular play.
Market Opened: Mar 29, 2026, 2:46 AM ET
Resolution Source
https://www.premiershiprugby.com/Resolver
0x69c47De9D...Harlequins hold a slim edge in trader consensus at 44.5% implied probability for their Gallagher Premiership clash against Sale Sharks at Twickenham Stoop, driven by home advantage despite a crippling injury list exceeding 25 players, including recent losses of Jarrod Evans, Nick David, and Cadan Murley following a 48-15 thrashing by Bath. Sale Sharks, at 39%, lurk close after a 26-17 Champions Cup win over Quins three weeks ago and boast George Ford's fifth-ranked 88 points, though their 0-6 away Premiership record and 85-19 drubbing by Saracens last weekend temper expectations. Both sides' WLWLL/LLWLL form, standout lineout steals from Quins flanker Guido Petti, and Sale's Ben Bamber's league-leading tackles underscore the razor-thin margins in this evenly matched Round 14 encounter.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedBeware of external links.
Beware of external links.


Beware of external links.
Beware of external links.
Frequently Asked Questions